Unknown PHASE4 INTERVENTIONAL 2-arm NCT04316377

Norwegian Coronavirus Disease 2019 Study (NO COVID-19)

Norwegian Coronavirus Disease 2019 Study: An Open Labeled Randomized Controlled Pragmatic Trial to Evaluate the Antiviral Effect of Chloroquine in Adult Patients With SARS-CoV-2 Infection

Sponsor: University Hospital, Akershus

Conditions Corona Virus Infection

Interventions Hydroxychloroquine Sulfate

Updated 7 times since 2020 Last updated: Jun 4, 2020 Started: Mar 25, 2020 Primary completion: May 25, 2020 Completion: Mar 3, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Corona Virus Infection, this trial is ongoing. The trial is conducted by University Hospital, Akershus and has accumulated 7 data snapshots since 2020. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

7 versions recorded

Apr 2025 — Present [monthly]

Unknown PHASE4

Status: Active Not Recruiting → Unknown
Sep 2024 — Apr 2025 [monthly]

Active Not Recruiting PHASE4
Jul 2024 — Sep 2024 [monthly]

Active Not Recruiting PHASE4
Jan 2021 — Jul 2024 [monthly]

Active Not Recruiting PHASE4
Jul 2020 — Jan 2021 [monthly]

Active Not Recruiting PHASE4

Status: Recruiting → Active Not Recruiting

▶ Show 2 earlier versions

May 2020 — Jul 2020 [monthly]

Recruiting PHASE4

Status: Not Yet Recruiting → Recruiting
Apr 2020 — May 2020 [monthly]

Not Yet Recruiting PHASE4

First recorded

Mar 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University Hospital, Akershus

Data source: University Hospital, Akershus

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Lørenskog, Norway